It was further discovered that a higher serum RANKL/OPG level is a prognostic factor associated with breast cancer metastasis.394 Currently, two ongoing trials are investigating the potential of denosumab in combination with chemotherapy to promote tumor inhibition (Table 4). The gene discussed is TNFSF11; the disease is breast cancer.